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Comparison between muscle strength and flexibility 
of the lower limbs of individuals with and without 
type 2 diabetes mellitus
Comparação entre pico de torque e flexibilidade dos membros inferiores de indivíduos com e 
sem diabetes mellitus tipo 2
Comparación entre pico de torque y flexibilidad de los miembros inferiores de individuos con y 
sin diabetes mellitus tipo 2
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ABSTRACT | To compare the muscle strength and flexibility 
of the lower limbs of individuals with and without T2DM. The 
method was a study of the types exposed and unexposed to 
T2DM. Individuals diagnosed with T2DM, individuals referred 
to electromyography, and those unexposed to T2DM were 
included. The exclusion criteria were: individuals over 70 years 
old; those who for some reason failed to complete one or 
both tests. The study population consisted of 64 individuals; 
34 (53.1%) exposed to DM and 30 unexposed, 50 (78.1%) 
were female, the mean age was 60.7±7.1 and the dominant 
lower limb was right in 57 (89.1%) individuals. Comparing 
individuals with and without a diagnosis of DM, one observed 
a reduction in the flexion torque on the left at a 120 ° angular 
velocity in diabetics individuals compared with nondiabetic 
patients, 25.94±2.26 vs 33.79±2, 4nm, p=0.027, respectively. 
The reduction in dorsiflexion torque on the right, at a 60 ° 
angular velocity was observed in diabetics compared with 
nondiabetic patients, 10.95±0.89 vs. 13.95±0.96nm, p=0.033, 
respectively. When comparing diabetic individuals with and 
without a diagnosis of PDN, one observed a greater flexion 
deficit among neuropathic individuals when compared with 
non-neuropathic individuals, 46.57±9.47 vs 11.63±13.85nm, 
p=0.049, respectively. No statistically significant differences 
were found when comparing groups exposed and unexposed 
to T2DM, and neuropathic and non-neuropathic diabetics.
Keywords | Muscle Strength; Type 2 Diabetes Mellitus; Muscle 
Strength Dynamometer; Torque; Lower Extremity.
RESUMO | O objetivo deste trabalho foi comparar o 
pico de torque e flexibilidade dos membros inferiores 
de indivíduos com e sem diabetes mellitus tipo 2 
(DM2). O método foi o estudo com grupos expostos 
e não expostos ao DM2. Foram incluídos indivíduos 
com diagnóstico médico de DM2, encaminhados para 
eletroneuromiografia, e não expostos ao DM2. Foram 
excluídos da pesquisa indivíduos com idade superior a 70 
anos ou que, por algum motivo, não conseguiram realizar 
um ou dois dos testes. A amostra foi não probabilística, 
composta por 64 indivíduos: 34 (53,1%) expostos ao DM2 
e 30 não expostos; 50 (78,1%) eram do sexo feminino, a 
idade média era de 60,7±7,1 anos, e o membro inferior 
dominante era o direito em 57 (89,1%) dos indivíduos. 
Comparando indivíduos com e sem diagnóstico de DM2, 
observou-se redução do torque de flexão à esquerda, em 
velocidade angular de 120° (25,94±2,26 vs. 33,79±2,4nm, 
p=0,027, respectivamente). Relatou-se menor valor do 
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torque de dorsiflexão à direita, em velocidade angular de 60°, 
dos diabéticos em relação aos não diabéticos (10,95±0,89 
vs. 13,95±0,96nm, p=0,033, respectivamente). Ao comparar 
indivíduos com DM2, com e sem diagnóstico de neuropatia 
diabética periférica (NDP), notou-se maior déficit de flexão entre 
os indivíduos neuropatas em comparação com não neuropatas 
(46,57±9,47 vs. 11,63±13,85nm, p=0,049, respectivamente). Não 
foram encontradas diferenças estatisticamente significativas 
ao comparar os grupos de expostos e não expostos ao DM2 e 
diabéticos neuropatas e não neuropatas.
Descritores | Força Muscular; Diabetes Mellitus Tipo 2; Dinamômetro 
de Força Muscular; Torque; Membros Inferiores.
RESUMEN | El objetivo de este trabajo fue comparar el pico de torque 
y la flexibilidad de los miembros inferiores de individuos con y sin 
diabetes mellitus tipo 2 (DM2). El método fue el estudio con grupos 
expuestos y no expuestos al DM2. Se incluyeron individuos con 
diagnóstico médico de DM2, encaminados para electroneuromiografía, 
y no expuestos al DM2. Se excluyeron de la investigación a individuos 
mayores de 70 años o que, por algún motivo, no pudieron realizar una 
o dos de las pruebas. La muestra fue no probabilística, compuesta 
por 64 individuos: 34 (53,1%) expuestos al DM2 y 30 no expuestos; 
50 (78,1%) eran de sexo femenino, la edad media era de 60,7±7,1 años, 
y el miembro inferior dominante era el derecho en 57 (89,1%) de los 
individuos. En comparación con individuos con y sin diagnóstico 
de DM2, se observó reducción del torque de flexión a la izquierda, 
en velocidad angular de 120° (25,94±2,26 frente a 33,79±2,4nm, 
p=0,027, respectivamente). Se ha reportado un menor valor del 
torque de dorsiflexión a la derecha, en velocidad angular de 60°, 
de los diabéticos con relación a los no diabéticos (10,95±0,89 
frente a 13,95±0,96nm, p=0,033, respectivamente). Al comparar 
individuos con DM2, con y sin diagnóstico de neuropatía diabética 
periférica (NDP), se notó mayor déficit de flexión entre los individuos 
neuropáticos en comparación con no neuropáticos (46,57±9,47 
vs. 11,63±13,85nm, p=0,049, respectivamente). No se encontraron 
diferencias estadísticamente significativas al comparar los grupos 
de expuestos y no expuestos al DM2 y los diabéticos neuropáticos 
y no neuropáticos.
Palabras clave | Fuerza Muscular; Diabetes Mellitus Tipo 2; 
Dinamómetro de Fuerza Muscular; Torque; Miembros Inferiores.
INTRODUCTION
Non-communicable chronic diseases (NCD) are 
considered a public health problem and the top cause of 
death in the world, many of them premature1-3. Out of 
the 38 million people who die from NCDs worldwide, 28 
million are from economically disadvantaged countries1,2,4. 
In Brazil, these diseases accounted for about 74% of 
deaths in 2012, in addition to their high morbidity rates3. 
Among the NCDs that cause most morbidities, diabetes 
mellitus (DM) stands out.
DM is not a single disease, but a group of metabolic 
disorders that have hyperglycemia in common. This 
biomarker results from defects in insulin secretion and/
or action5. According to the classification suggested by 
the American Diabetes Association6,7 and the World 
Health Organization2, there are four types of DM: type 1 
(T1DM), type 2 (T2DM), gestational, and other specific 
types of DM. T2DM is the most prevalent, being present 
in 90 to 95% of the cases5.
T2DM is characterized by a defect in both the action 
and secretion of insulin when hyperglycemia is manifested. 
In most cases, both defects are present, but one of them may 
be prevalent. Generally, T2DM is manifested after the age 
40, but it can occur at any age depending on one’s lifestyle 
habits. In this type of DM, patients are not dependent on 
exogenous insulin to survive; however, in some cases, their 
use is necessary for a proper glycemic control5.
As the main chronic complication of T2DM, 
peripheral diabetic neuropathy (PDN) occurs at the 
microvascular level and affects about 50% of diabetics over 
the years, the lower limbs being the most affected area8. It 
is characterized by irreversible change in nerve structure 
and function, due to demyelination, axonal atrophy and 
decreased regenerative potential, causing symmetrical 
pain, sensorimotor loss, and paresthesia8. In most cases, 
it affects the individual’s quality of life8 and increases the 
risk of foot ulcers, amputations, cardiovascular morbidity, 
and mortality in general9.
Longitudinal and cross-sectional studies have suggested 
T2DM is associated with decreased muscle quality, power 
and strength, with greater severity in the lower limbs than 
in the upper limbs10-12. This reduction is worsened in the 
presence of PDN and coronary artery disease (CAD) due 
to their effects of blood flow deficiency13. As a consequence 
of these factors, muscle atrophy occurs especially in the 
lower limb distal segment14,15. Therefore, muscle quality, 
power and strength are not the only changes in nerve 
function caused by T2DM, since premature muscle fatigue 
can also influence these factors16,17. Therefore, such changes 
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may be the main causes of limitations and of a high level 
of functional and physical disabilities reported by this 
population18-20. In this way, this study aimed to compare 
the muscle strength and flexibility of the lower limbs of 
individuals with and without T2DM.
METHODOLOGY
This is a study of the types exposed and unexposed to 
T2DM. Sixty-four outpatients with and without diagnosis of 
Type 2 Diabetes Mellitus were included in the sample. This 
study was conducted at the Laboratory of Biomechanics of 
Faculdade de Educação Física e Fisioterapia (FEFF) from 
Universidade de Passo Fundo (UPF), at the outpatient 
clinics of neurology, endocrinology and clinical medicine of 
Hospital São Vicente de Paulo (HSVP) and at the private 
clinic Serviço de Neurologia e Neurocirurgia (SNN), all 
located in the city of Passo Fundo (RS).
Study population
The study population consisted of individuals diagnosed 
with T2DM cared for at the HSVP outpatient clinics 
and of individuals unexposed to T2DM, also recruited 
at outpatient clinics within the same institution.
Inclusion criteria
Individuals cared for at the outpatient clinics of 
neurology, endocrinology and clinical medicine of the 
HSVP, diagnosed with T2DM through electromyography, 
and individuals unexposed to T2DM, recruited through 
an announcement displayed at the participating hospital, 
were included.
Exclusion criteria
Individuals aged over 70 years or who, for some reason, 
were unable to perform one test or both of them (tests of 
peripheral muscle strength of lower limbs and/or flexibility 
test) were excluded.
Sampling procedure and data collection
A non-probability sampling was used. Individuals who 
met the inclusion criteria signed the Informed Consent 
Form (ICF), and the study evaluations were performed 
at the FEFF/UPF, on a previously scheduled date and 
time. Then, data collection was started by filling the 
medical record and the sociodemographic questionnaire. 
Subsequently, the flexibility test and the tests of lower limb 
muscle strength (knee flexion and extension, ankle plantar 
flexion and dorsiflexion) were applied at the Laboratory 
of Biomechanics of FEFF. These data were collected by 
the researcher and study collaborators, recorded in paper 
forms and sequentially numbered according to the order 
of evaluation.
Statistical analysis
The data collected were typed into an Excel spreadsheet, 
and statistical analysis was performed using IBM SPSS 
Statistics (version 22) for Windows. Numerical variables 
were described as mean±standard deviation or median 
(percentile25 - percentile75) as they presented normal 
distribution or not. Numerical variables were expressed 
as absolute or relative frequency. The associations between 
exposure to diabetes or peripheral diabetic neuropathy and 
(1) age, height, body mass, body mass index (BMI) and 
flexibility were evaluated using the analysis of variance 
with a classification criterion; (2) gender and dominance, 
using the Pearson Qui-squared test with correction for 
continuity. Comparisons of the distribution of peak torque 
measurements between groups of individuals exposed and 
unexposed to diabetes, or exposed or unexposed to peripheral 
diabetic neuropathy were performed using analyses of 
covariance, in which each peak torque measurement was 
defined as outcome, exposure to diabetes as an independent 
variable, and age and body mass index as covariables. Age-
adjusted estimated mean torque peaks were described 
with their respective standard error estimates. Values were 
considered statistically significant when p<0,05.
Protocols used
(1) Clinical assessment form.
(2) Computerized isokinetic dynamometer Biodex Multi 
Joint System 3 Pro: first, body mass, height, blood pressure 
(BP), and heart rate (HR) of all study participants were 
checked before the isokinetic evaluation. Subsequently, 
they performed cycling warm-up in an electromagnetic 
spinning bike (Movement BM 2700) without workload 
for five minutes and, afterwards, each individual was 
referred to the isokinetic dynamometer for evaluations.
Then, knee joints (bilateral) were evaluated in flexion and 
extension movements at angular velocities of 120, 180, 
and 240 °/s. The individuals were comfortably positioned 
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in the chair of the equipment supporting the back at 85 ° 
and adjusting it until the popliteal fossa was supported on 
the front of the seat. Stabilizing the trunk was needed, thus 
safety belts were used. Two of them crossed the anterior 
chest and one was positioned horizontally in the pelvic 
region. To better secure the thigh, a velcro strap was used 
above the knee and two centimeters above the medial 
malleolus, stabilizing the leg making the movement. The 
axis of rotation of the dynamometer was aligned with 
the axis of the knee joint. Before starting the test, the 
participants made three free extension-flexion movements 
so that all individuals could become acquainted with 
the equipment. Finally, a series of five repetitions of the 
knee flexion and extension movements was performed, 
through a concentric contraction of the agonist muscle 
group followed by another one of the antagonist group, 
with a 60-second interval between each angular velocity.
To evaluate the peak torque of the plantar flexors and 
ankle dorsiflexors, the individual was placed in supine 
position on the bench, with hips and knees bent at 80° and 
30 °, respectively, and the knees supported in the popliteal 
area. The knee and ankle to be tested and the lumbar 
region were stabilized using a sturdy cushion, and the 
contralateral foot rested on a support. The individual’s hands 
were placed on the armrest. Dorsal flexion and plantar 
flexion were tested at 30 and 60 °/s angular velocities. 
Each movement was repeated five times at both velocities 
through a concentric contraction of the agonist muscle 
group followed by another one of the antagonist group, with 
rest intervals of 60 seconds between each angular velocity.
The parameters of the isokinetic dynamometry 
evaluated for the different knee and ankle movements 
were peak torque (PT), muscle deficit between right and 
left limbs, and agonist/antagonist relationship, respectively.
(3) Sit and reach box – WCS Cardiomed: sit and reach 
test. In this test, the subject was seated on a mat, with the 
arms fully in contact with the front of the seat and the lower 
limbs with knees extended and hips bent. After correctly 
positioned, the individuals were instructed to push the scale 
ruler of the bench forward as far as possible, thus bending 
the trunk. The value obtained for each trial was expressed in 
centimeters and immediately written down by the evaluator. 
The participants made three attempts and the one whose 
value was higher was considered for data analysis.
Ethical considerations
The voluntary character, without prejudice to the 
assistance in case of refusal, is guaranteed to all the 
individuals who participated in this study. Possibly, 
the muscle discomfort from the (biomechanical and 
flexibility) evaluations was the only additional discomfort 
determined by the participation. The benefits were not 
direct, but the participants could have their muscles and 
flexibility of the lower limbs reliably evaluated. The results 
and medical records of the evaluations were hand over to 
the participants, who were provided with explanations 
and clarified their doubts with the researcher responsible. 
Therefore, being aware of the results, the participants can 
seek treatment (since it will not be given by the researcher) 
to reduce the effects of decreased lower limb strength, 
according to the orientations provided.
RESULTS
The study population consisted of 64 individuals, 
34 (53.1%) exposed to DM and 30 unexposed to DM. 
Among them, 50 (78.1%) were female, the mean age was 
60.7±7.1 years, and the right lower limb was dominant 
in 57 (89.1%) individuals. As described in Table 1, the 
individuals exposed to DM were older, 62.8±6.73 vs. 
58.2±6.94 years, p=0.009, and their BMI was higher, 
29.82±5.20 vs. 27.99±3.89 kg/m², p=0.027, than that of 
those unexposed to T2DM, respectively. No statistically 
significant difference between the groups was observed 
regarding dominance, weight, height, and flexibility.
Table 1. Sample description
Groups
Unexposed to 
T2DM
(n=30)
T2DM
(n=34) p
Gender (F) 24 (80.0 %) 26 (76.5%) 0.970
Dominance (D) 28 (93.3%) 29 (85.3%) 0.531
Age (years) 58.2±6.94 62.8±6.73 0.009
Weight (kg) 70.4±10.9 76.6±14.5 0.058
Flexibility 21.06±8.69 23.13±10.65 0.401
Height 1.60±0.07 1.60±0.094 0.845
BMI 27.99±3.89 29.82±5.20 0.027
Values express absolute and relative frequency or mean±standard deviation.
When comparing individuals with and without 
T2DM diagnosis, lower values of flexion torque on 
the left, at a 120 ° angular velocity, were observed for 
those diagnosed with T2DM compared with those 
unexposed to T2DM, 25,94±2,26 vs, as Table 2 shows. 
33.79±2.4nm, p=0.027, respectively.
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Table 2. Comparison of the peak torque of extensor and flexor muscles between groups: unexposed to T2DM and exposed to T2DM; 
T2DM without PDN and T2DM with PDN
Group
p
Group
pUnexposed to 
T2DM
(n=30)
T2DM
(n=34)
Without PDN
(n=11)
PDN
(n=23)
Angular velocity 120 °
Right extension 76.06±5.3 73.2±4.9 0.703 73.91±7.69 73.22±5.26 0.942
Left extension 80.15±4.7 70.07±4.4 0.141 77.52±7.00 65.07±4.78 0.158
Extension deficit 18.67±6.3 23.5±6.2 0.612 15.10±6.65 22.82±4.55 0.353
Right flexion 30.5±2.5 27.37±2.4 0.264 26.20±3.66 26.56±2.50 0.936
Left extension 33.79±2.4 25.94±2.26 0.027 28.41±3.45 23.66±2.36 0.271
Flexion deficit 31.04±8.32 39.95±7.77 0.458 11.63±13.85 46.57±9.47 0.049
Angular velocity 180 °
Right extension 64.23±4.76 60.89±4.44 0.625 62.40±7.62 60.89±5.21 0.874
Left extension 66.83±3.96 60.65±3.7 0.279 67.91±6.12 56.28±4.18 0.133
Extension deficit 18.08±4.8 18.96±4.5 0.899 20.79±5.02 14.96±3.43 0.352
Right flexion 30.36±2.3 24.54±2.16 0.083 23.01±3.43 25.03±2.34 0.635
Left extension 31.05±2.25 25.58±2.10 0.094 28.79±3.41 23.41±2.33 0.208
Flexion deficit 23.50±4.07 25.30±3.80 0.757 29.14±5.89 25.26±4.02 0.596
Angular velocity 240 °
Right extension 58.61±4.26 55.01±3.98 0.557 59.88±7.12 53.22±4.87 0.453
Left extension 60.65±3.64 52.86±3.40 0.140 58.46±5.53 49.81±3.78 0.214
Extension deficit 16.33±3.93 14.83±3.68 0,790 12.26±4.35 15.87±2.97 0.504
Right flexion 28.82±2.16 25.10±2.02 0.234 27.21±3.59 24.10±2.45 0.487
Left extension 30.02±2.04 24.93±1.91 0.087 28.39±3.21 23.40±2.19 0.215
Flexion deficit 15.35±3.33 21.12±3.11 0.231 22.56±5.37 18.74±3.67 0.567
T2DM: type 2 diabetes mellitus; PDN: peripheral diabetic neuropathy; p: probability value. Values express mean±standard error, adjusted by age and BMI.
As described in Table 3, reduction in dorsiflexion 
torque on the right was observed for individuals exposed 
to T2DM and unexposed to T2DM, at a 60 ° angular 
velocity compared with those unexposed to T2DM, 
10,95±0,89 vs. 13.95±0.96nm, p=0.033, respectively. 
No statistically significant differences were observed 
between groups regarding the other biomechanical 
measurements. 
Table 3. Comparison of the peak torque of plantar flexor and dorsiflexor muscles between groups: unexposed to T2DM and exposed to 
T2DM; T2DM without PDN and T2DM with PDN
Group Group
Unexposed to 
T2DM
(n=30)
T2DM
(n=34) p
Without PDN
(n=11)
PDN
(n=23) p
Angular velocity 30 °
Right plantar flexion 52.61±3.54 46.92±3.31 0.266 51.42±5.80 43.37±3.69 0.268
Left plantar flexion 57.81±3.58 48.20±3.34 0.065 52.39±5.26 44.36±3.59 0.224
Deficit in plantar flexion 20.10±4.29 25.09±4.00 0.418 18.33±6.90 27.94±4.71 0.266
Right dorsiflexion 18.79±1.95 14.39±1.82 0.120 15.23±1.50 14.19±1.02 0.581
Left dorsiflexion 17.02±1.31 14.70±1.22 0.220 15.08±1.88 14.63±1.28 0.848
Dorsiflexion deficit 33.66±9.13 26.62±8.53 0.592 14.12±10.68 32.95±7.30 0.162
Angular velocity 60 °
Right plantar flexion 45.91±2.93 40.18±2.74 0.177 43.57±4.98 37.63±3.41 0.340
Left plantar flexion 47.74±3.11 39.1±2.91 0.057 45.40±4.68 35.08±3.20 0.083
Deficit in plantar flexion 18.58±3.16 20.67±2.95 0.645 11.22±5.68 24.98±3.88 0.058
Right dorsiflexion 13.95±0.96 10.95±0.89 0.033 12.64±1.16 10.83±0.79 0.217
Left dorsiflexion 14.02±1.17 10.92±1.09 0.070 11.48±1.78 10.94±1.21 0.806
Dorsiflexion deficit 34.71±8.42 20.58±7.86 0.244 25.30±4.40 20.77±3.00 0.409
T2DM: type 2 diabetes mellitus; PDN: peripheral diabetic neuropathy; p: probability value.
Values express mean±standard error, adjusted by age and BMI.
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When comparing diabetic individuals with those 
without PDN diagnosis, neuropathic individuals 
showed greater flexion deficit compared with non-
neuropathic individuals, 46,57±9,47 vs, as described 
in Table 2, 11.63±13.85nm, p=0.049, respectively. 
No statistically significant differences were observed 
between groups regarding the other biomechanical 
measurements (Tables 2 and 3). 
DISCUSSION
In this study, no consistent reduction in biomechanical 
measurements was observed both for individuals with 
T2DM compared with individuals without T2DM and 
for individuals with T2DM and peripheral diabetic 
neuropathy compared with those without neuropathy. 
However, although no statistically significant, the mean 
values both for individuals with T2DM compared 
with individuals without T2DM and for neuropathic 
individuals compared with non-neuropathic ones suggest 
there may be a reduction in torque in these populations, 
but the study has no statistical power to show it.
The effect of T2DM on muscle strength, especially 
in the lower limbs, has been confirmed in many studies, 
in addition to the correlation between the severity of 
PDN, glycated hemoglobin, and other factors, with the 
reduced strength17,20-26. Some studies affirm that muscular 
strength is affected by gender, age, and body mass index 
(BMI)27. However, if muscle strength is normalized by 
the cross-sectional area or muscle mass, the influence of 
the gender could be diminished26,28.
A study conducted in 2014 tested the hypothesis 
that diabetic patients’ muscles were weaker than those of 
healthy individuals. Twelve patients diagnosed for more 
than 10 years, 18 patients diagnosed for less than 10 
years and 20 healthy individuals, of both genders, were 
evaluated and compared without obtaining significant 
difference between the groups. This result may have 
been influenced by the age, gender and small sample 
size. Maximum peak torque values for flexors and for 
knee extensors were not affected both in isometric and 
in isokinetic tests. Also, it was clearly shown that men 
were significantly stronger than women. In this study, 
a statistically significant difference was obtained only 
in the variable “angular velocity of 120 ° in the flexion 
movement of the left knee” (p=0.027), and, in the other 
17 variables, no statistically significant difference was 
found (p>0.05).
In 2012, the study by Ijzerman et al. aimed to distinguish 
the effects of T2DM and PDN on muscle strength, quality 
of life, and mobility. The sample was composed of 98 patients 
with PDN, 39 patients without PDN, and 19 healthy 
individuals, of both genders17. They performed isometric 
and isokinetic tests to evaluate the muscular strength of 
the lower limbs (ankle plantar flexors and dorsiflexors, 
knee flexors and extensors), SF36 to evaluate the quality 
of life, and six-minute walk test (6MWT), timed up and 
go test (TUGT), and a physical activity questionnaire 
adapted for the elderly to evaluate the mobility of the study 
participants. As a result, both the group with PDN and 
that without PDN obtained lower values in the maximal 
voluntary strength and in all the parameters measured for 
knee and ankle than those of the control group, but with 
a statistically significant difference only in the flexion 
movement of knees, corroborating this study. In addition, 
no differences were observed between T2DM individuals 
with and without PDN17.
Another study by Ijzerman et al.30 tested the hypothesis 
that the reduction in muscle strength in T2DM 
patients without clinically diagnosed PDN resulted 
from premature nerve damage and that those clinically 
diagnosed with PDN showed greater muscle weakness 
than T2DM patients without clinically diagnosed PDN 
due to increased degradation of the motor nervous system. 
However, the values obtained in the study agreed with 
this hypothesis, and the authors suggested the reduction 
in voluntary muscle strength occurs regardless of motor 
loss or loss of sensory nerve function in T2DM patients 
with and without PDN.
In the previous study, the authors suggested three valid 
conclusions: the first one was that the group of T2DM 
patients with PDN showed compound muscle action 
potential, suggesting a smaller amount of muscle mass 
between the two groups; the second one was that the 
conduction speed was reduced in the group of T2DM 
patients with PDN, showing deterioration of nerve 
function; and the third was that muscle strength was 
relatively lower in the group of T2DM patients without 
PDN than in the control group30.
In 2014, Allen et al.31 evaluated the effects of PDN 
on muscle contraction and their relationship with muscle 
morphology and denervation. Twelve patients (seven 
men and five women aged between 32 and 78 years) with 
(non-insulin dependent) T2DM and PDN, confirmed 
through clinical characteristics and electrophysiological 
study, and twelve healthy individuals (with the same 
gender distribution as that of the other group, but aged 
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between 29 and 77 years) were part of the control group. 
To evaluate the strength in the dorsiflexion movement, 
an isometric test was performed only on the dominant 
leg. It was different from this study, in which both legs 
were used for evaluation of dorsiflexors and ankle plantar 
flexors, as well as of flexors and knee extensors, and the test 
was isokinetic (concentric agonist/concentric antagonist). 
However, in the study by Allen et al., reduced muscle 
strength was found for the group of patients with T2DM 
and PDN, and the reduction in other markers of the 
tibialis anterior was statistically significant.
Regarding the evaluation method, few studies found 
used the isokinetic evaluation. Some of them used the 
isometric evaluation method or, as in the case of two 
studies cited above, both methods. In addition, the values 
shown both in the biomechanical evaluations and in 
the flexibility assessments for a large part of the group 
of individuals unexposed to T2DM also agreed with 
the hypotheses of this study, which may indicate an 
important signal because the values remained below what 
was expected for some patients, even without T2DM. 
Therefore, individuals who do not develop T2DM also 
need a more detailed follow-up and investigations on the 
muscle health of their lower limbs.
CONCLUSIONS
Based on the results, we can conclude that consistently 
lower values of the biomechanical measurements and the 
flexibility of individuals exposed to T2DM evaluated 
were not found when compared with those of individuals 
unexposed to T2DM. In addition, no lower values of 
the aforementioned measurements were found when 
comparing T2DM individuals with PDN and T2DM 
individuals without PDN.
The mean values of this sample suggest a decrease in 
peak torque may exist, even without statistical significance. 
However, our study has no statistical power to show it.
An important result was realized throughout this study. 
Some of the individuals of the group unexposed to T2DM 
showed results above the expected in the biomechanical 
tests and in the flexibility test. On the other hand, diabetic 
individuals with and without PDN showed good results 
in both tests. Therefore, we emphasize the importance of 
encouraging physical activity and knowledge of T2DM, 
since a large part of these individuals performed some type 
of activity and were aware of the effects of this disease in 
the short and, mainly, long term.
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